跳至主要内容
临床试验/EUCTR2016-001357-40-DE
EUCTR2016-001357-40-DE进行中(未招募)1 期

High-Flow-Therapy for the treatment of Cheyne-Stokes-Respiration in chronic heart failure: A randomized, controlled, cross-over trial - Float-CS

Klinik für Kardiologie, Herz- und Diabeteszentrum NRW0 个研究点目标入组 20 人开始时间: 2016年6月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age 18-90 years
  • New York Heart Association (NYHA) class II to IV
  • Left ventricular ejection fraction = 45%
  • Predominantly central sleep apnea (AHI =15 events per hour, with >80% central events [apnea or hypopnea] and a central AHI of =10 events per hour)
  • Hypoxemic burden = 25%
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 12
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 8

排除标准

  • daytime hypercapnia (pCO2 > 45 mmHg)
  • ongoing ventilation therapy
  • cardiothoracic surgery within the last 3 months
  • myocardial infarction within the last 6 months
  • unstable angina
  • acute myocarditis
  • stroke within the last 3 months
  • epilepsy, known cerebral damage, dementia
  • untreated restless-legs-syndrome

研究者

发起方
Klinik für Kardiologie, Herz- und Diabeteszentrum NRW

相似试验